The approval of the ATO-C for the first in human trial in Republic of Korea (Adult tissue derived organoid based regenerative dedicine)
TISSUE ENGINEERING PART A（2022）
Key words
Organoid, Regenerative medicine, Efficacy, Safety, Refractory ulcer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined